Hi-Clearance Inc. (TPEX:1788)

Market Cap	5.99B -6.3%
Revenue (ttm)	4.37B +5.2%
Net Income	388.24M +11.5%
EPS	10.65 +36.4%
Shares Out	44.52M
PE Ratio	12.63
Forward PE	n/a
Dividend	7.00 (5.20%)
Ex-Dividend Date	Jun 16, 2026

Volume	41,285
Open	134.00
Previous Close	134.00
Day's Range	133.50 - 134.50
52-Week Range	133.50 - 145.00
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1788

Financial Performance

In 2025, Hi-Clearance's revenue was 4.28 billion, an increase of 5.04% compared to the previous year's 4.07 billion. Earnings were 368.51 million, an increase of 2.45%.